Lymph chylomicrons labeled with 14 C-cholesterol and plasma very low and intermediate density lipoproteins (d < 1.019) labeled with 3 H-cholesterol were injected simultaneously into recipient cholesterol-fed rabbits. The cholesteryl ester of chylomicron origin ( 14 C) found in the tissues 1 to 4 hours after the injection is the sum of both direct and indirect uptake of chylomicron cholesteryl ester. The direct uptake of chylomicron cholesteryl ester is defined as occurring in situ during the interaction between chylomicrons and lipoprotein lipase in endothelial cells. The indirect uptake of chylomicron cholesteryl ester results from the uptake of chylomicron remnants and of other plasma lipoproteins which become labeled during the degradation of the injected chylomicrons by net lipid transfer or by exchange. The indirect contribution of chylomicron cholesteryl ester to tissues was calculated from tissue 3 H-cholesteryl ester derived from injected plasma d < 1.019 lipoproteins. In rabbits fed 0.5 g cholesterol daily for 40-60 days, with plasma cholesterol concentrations between 20 and 30 mM (800-1200 mg/dl), less than 1% of the cholesteryl ester influx into aortic intima media and less than 10% in liver was derived from the direct uptake of chylomicron cholesteryl ester. (Arteriosclerosis 2:493-499, November/December 1982) C holesterol-containing chylomicrons may be atherogenic 1 because of two possible mechanisms: the direct and the indirect pathways. By the direct pathway, circulating chylomicrons would be adsorbed onto the arterial surface and degraded by lipoprotein lipase to remnants in situ before deposition of their cholesterol in the arterial intima. By the
indirect pathway, chylomicrons would be degraded by lipoprotein lipase anywhere in the capillary network and then be released as chylomicron remnants which would be largely removed by the liver, but might also be deposited in the arterial wall. When circulating remnants are present in plasma, they are found in the d < 1.019 plasma lipoprotein fraction. We have recently demonstrated that, in hypercholesterolemic rabbits, approximately 50% of the aortic cholesteryl ester uptake is derived from d < 1.019 lipoproteins. 2 In the present study, we attempted to calculate the relative contribution of chylomicron cholesteryl ester to the aorta and liver by both the direct and the indirect pathways. After injection of a mixture of lymph chylomicrons and d < 1.019 plasma lipoproteins labeled in the cholesterol fractions with 14 C and 3 H, respectively, we measured tissue radioactivities and attempted to correct the influx of labeled cholesteryl ester for the effects of cholesteryl ester exchange and metabolic transfer between lipoprotein fractions.
Methods

Animals
Female New Zealand White rabbits (2-3 kg) were obtained from Dutchland Laboratories, Denver, Pennsylvania. Each rabbit was housed in a stainless steel cage under controlled environmental conditions and fed 100 g daily of Purina Laboratory Rabbit Chow (Ralston Purina, St. Louis, Missouri). The cholesterol-enriched diet contained 0.5 g of cholesterol (U.S.P., Nutritional Biochemicals, Cleveland, Ohio) and 2.7 g of oil (Wesson Oil, Hunt Wesson, Fullerton, California) per 100 g of diet.
Isotope Purity
We obtained 1a, 2 a (n)-3 H-cholesterol and 4-14 Ccholesterol from Amersham Corporation (Arlington Heights, Illinois). Immediately before use, we determined the purity by chromatography on precoated TLC plates (silica gel 60, E. Merck, Darmstadt, Germany) in a hexane/diethyl ether/glacial acetic acid, 50:50:1 (vol/vol) solvent system. The material was used only if more than 95% of the labeled sterol comigrated with dibromide-purified cholesterol. The equivalency of 3 H-and 14 C-cholesterol was determined after oral or intravenous administration of a mixture of the two isotopic forms of cholesterol. The 3 H to 14 C ratios in plasma samples and in tissues, obtained 24 hours after the isotope administration, were within 2% of that of the administered doses.
Donor Animals
Preparation of In Vivo Labeled Chylomicrons
Before cannulation of the thoracic duct and of the duodenum, 3 the donor rabbits were fed a cholesterol-free diet. When the animals had recuperated from surgery and had begun to eat and defecate, they were infused intraduodenally with a fat emulsion composed of 4.5% Wesson oil, 3.6% soy lecithin, 2% albumin, 0.9% NaCI, 0.3% sodium taurocholate, and 50 mM cholesterol 4 (at 4 ml/hour). When the lymph appeared milky, usually 2 to 3 hours after the start of the infusion, we mixed labeled cholesterol, dissolved in 0.2 ml of ethanol, with 200 mg of sodium taurocholate (Difco Laboratories, Detroit, Michigan) in 10 ml of 0.9% NaCI and introduced it as a bolus into the duodenal infusion tube. Lymph was collected at 4°C with ethylenediaminetetraacetic acid (EDTA) as an anticoagulant. Most of the labeled cholesterol appeared in the lymph between 8 and 16 hours after the administration of the labeled cholesterol. About 30% of the administered labeled cholesterol was recovered in the lymph during the first 24 hours. The lymph was centrifuged at 8 x 10 8 g x min at 10°C in a SW 27 Beckman rotor. The chylomicron layer was separated by tube slicing and the chylomicrons were resuspended by forcing them through a 20-gauge needle in the presence of 0.9% NaCI. The chylomicron suspension was adjusted to 20% sucrose, layered underneath 0.9% NaCI, and recentrifuged under the same conditions. 4 The chylomicrons were resuspended through a 20-gauge needle and the suspension was dialyzed at 4°C against 0.9% NaCI. Immediately before use, the chylomicrons were filtered through a 0.45 jum filter and then through a 0.22 jum filter (Millipore Filter Corporation, Bedford, Massachusetts).
Preparation of In Vivo Labeled Plasma Lipoproteins
The 3 H-cholesterol (2-5 mCi) and 0.5 mg of carrier cholesterol in benzene were dried under nitrogen, redissolved in 0.2 ml ethanol, and added to 10 ml of 0.9% NaCI containing 200 mg sodium taurocholate. The mixture was given by stomach tube to donor rabbits that had been fed the cholesterol-enriched diet for 4-6 days. The donor animals were exsanguinated 16-20 hours after the administration of the doses, and the blood was collected in the presence of EDTA. The plasma was ultracentrifuged at d = 1.019 in a 60 Ti Beckman rotor, as described previously. 5 The lipoprotein preparations were dialyzed overnight against 0.9% NaCI at 4°C and filtered through 0.22 ptm Millipore filters immediately before use.
Recipient Animals
A mixture of 3 H-d < 1.019 plasma lipoproteins and 14 C-lymph chylomicrons was injected into the marginal ear veins of recipient rabbits fed the high cholesterol diet for 40-60 days. The plasma cholesterol concentration of these animals was between 20 and 30 mM. Serial blood samples were taken from the other ear vein with EDTA as an anticoagulant. At the end of the experiment, the rabbits were anesthetized, the thoracic cavity was opened, and a blood sample was withdrawn from the inferior vena cava. The inferior vena cava was then severed and 0.5 I cold saline was infused into the left ventricle of the heart. The fluid in the thoracic cavity was removed by suction. The thoracic portion of the aorta was dissected free and the adventitia was removed under a stream of saline. The aorta was opened longitudinally and the intimal surface was rinsed again with saline. The intima-media was separated by dissection. These preparations weighed 0.2 to 0.3 g, with an intimal surface area of about 10 cm 2 . Samples of liver and aorta were stored at -20°C within 15 to 30 minutes after the animal was killed. The plasma was kept at 4°C for less than 5 hours before further processing.
Analytical Procedures
After the intravenous injection of the chylomicron preparations, attempts were made initially to reisolate the circulating chylomicrons (S, > 400). Plasma samples (3 ml) were mixed with an equal volume of 40% sucrose in 0.9% NaCI in a 3.5 inch centrifuge tube. This mixture was overlayered with 12 ml of 10% sucrose in 0.9% NaCI and then with 1 ml of 0.9% NaCI. The samples were centrifuged in a SW 40.1 Beckman rotor at 1.2 x 10 8 g x min at 4°C, and the top 1 ml was removed by tube slicing. The cholesterol-to-triglyceride ratio (wt/wt) of this floating fraction was approximately 10, which is much larger than the ratio of 0.05 for the lymph chylomicrons of cholesterol-fed rabbits. Even in overnight-fasted hypercholesterolemic rabbits, about 20% of the plasma cholesterol floated to the top 0.5 cm of the centrifuge tube, although in cholesterol-fed rabbits chylomicron triglyceride is rapidly removed from circulation. 6 Apparently even postabsorptive hypercholesterolemic plasma contains appreciable amounts of cholesterol-rich, triglyceride-poor particles that float like chylomicrons during ultracentrifugation. In subsequent experiments these particles were not separated from the other very low density lipoproteins (VLDL) or d < 1.019 lipoproteins.
Plasma samples were adjusted to d = 1.019 and centrifuged at 4°C for 1.58 x 10 s g x min in a 40.3 Beckman rotor. The top and bottom fractions were separated by tube slicing. Some plasma samples were also centrifuged at d = 1.006 and d = 1.063. Aliquots of whole plasma and of the various ultracenttifuged fractions were adjusted to 73% ethanol. After the addition of hexane and water, the lipids were partitioned between hexane and the aqueous alcohol phase. 7 Aliquots of the hexane phase were used for determination of radioactivity in total cholesterol and for separation of free and esterified cholesterol by thin layer chromatography. 8 Lipids were extracted from silica gel with chloroform:methanol (9:1, vol/vol). Aliquots were taken for a determination of the cholesterol by the ferric chloride method 9 after saponification. 10 When no determination of cholesterol mass was needed, the silica gel was scraped directly into vials prefilled with scintillator. A toluenebased scintillator with 2% ethanol was used for the determination of radioactivity. The vials were counted in a liquid scintillation counter (Beckman LS 8100) to a SD of less than 1 %. Efficiency and overlap corrections were made by reference to calibrated samples of 3 H-and 14 C-toluene (Amersham). The radioactivities in free and esterified cholesterol were corrected for recoveries after thin layer chromatography (95%-98%) and the values in each top and bottom fraction were corrected for recoveries after ultracentrifugation (90%-100%). Identical recoveries of free and esterified cholesterol showed that no esterification of free cholesterol took place during ultracentrifugation.
The cholesterol mass in each fraction was calculated after correction for thin layer chromatography and ultracentrifugation recoveries. For each animal, free and esterified cholesterol concentrations in the lipoprotein fractions were determined on the first and last plasma samples. The average free and esterified cholesterol specific activities of each lipoprotein fraction over the experimental period were calculated from the area under the specific activity-time curves.
Tissue samples were minced and lipids were extracted during 24 hours with 20 volumes of chloroform/methanol 2:1 (vol/vol). 11 After the filtered lipid extract was washed according to the procedure of Folch et al., 11 radioactivity in free and esterified cholesterol was determined as described for the plasma lipid extract. To monitor possible contamination of these low counting samples, nonradioactive "blank" samples were carried through the entire procedure. Some samples were counted for up to 300 minutes, resulting in a SD of less than 5% for 14 C and 3 H samples.
Results
The isolation of the chylomicron fraction by centrifugation and the subsequent washing procedures might have partially denatured these lipoproteins or might have removed surface components involved in their interaction with the aorta or liver. To test this possibility, we prepared 3 H-cholesterol-labeled lymph chylomicrons in the usual manner and recombined them with the chylomicron subnatant fraction obtained from the first centrifugation of lymph. This reconstituted 3 H-labeled whole lymph was infused intravenously over a period of 6-8 hours into rabbits which simultaneously were infused intraduodenally with a fat plus 14 C-cholesterol suspension. Two rabbits were treated in this manner and two were treated with the isotopes reversed. The intravenous infusion rate was adjusted periodically so that the time-dependent profiles of the 3 H-and 14 C-cholesterol in a given plasma lipoprotein fraction were approximately superimposable (figure 1). To obtain tissue uptakes, the quantity of tissue 3 H-and u C-cholesteryl ester per gram was divided by the corresponding Figure 1 . Plasma labeled cholesteryl ester during intraduodenal and intravenous lipid injections. Oil and 14 C-cholesterol were infused intraduodenally and 3 H-cholesteryl ester labeled chylomicrons were injected intravenously. area under the plasma isotope concentration vs the time curve. The uptake is thus expressed as "clearance," i.e., in ml of plasma/g of tissue.
For aortic intima-media, the average ratio of cholesteryl ester clearance calculated from intravenously infused chylomicrons to the clearance calculated from the duodenally infused lipid emulsion was 1.03 ± 0.32 (SD), with individual ratios of 1.4,0.6,1.0, and 1.1. This shows that, as far as the aorta is concerned, the intravenously infused chylomicron cholesteryl ester was taken up at the same fractional rate as cholesteryl ester delivered to plasma during normal fat absorption. A larger difference was found for the uptake of cholesteryl ester by the liver. In four rabbits the average uptake ratio of injected to native chylomicrons was 0.58 ± 0.38 with individual values of 1.13, 0.53, 0.35, and 0.32. Thus, on the average, liver tissue removed cholesteryl ester from the plasma more rapidly if the ester resulted from the degradation of native chylomicrons rather than from the degradation of the intravenously infused isolated chylomicrons.
Labeled Cholesteryl Ester In Plasma
Chylomicrons, labeled with 14 C-cholesterol, and plasma d < 1.019 lipoproteins from a hypercholesterolemic donor rabbit, labeled with 3 H-cholesterol, were injected simultaneously into recipient rabbits. Figure 2 shows a typical set of curves of the disappearance of labeled cholesteryl ester from plasma. Extrapolation of the disappearance curves to zerotime shows a dilution volume of 34 ± 2 ml/kg for the cholesteryl ester injected as d < 1.019. This is close to the 33 ± 3 ml/kg of body weight determined by Evans Blue dilution in similar animals. 6 As eahy as 10 minutes after injection, the percentage of 14 Ccholesteryl ester in the plasma, injected as chylomicrons, was consistently less than that of the ^-cholesteryl ester injected as d < 1.019 lipoproteins ( figure 2 ). The figure also shows that the later phases~ of plasma clearance of the two labeled cholesteryl ester fractions are essentially parallel. The difference between the average plasma cholesteryl ester radioactivities during the experimental period, expressed as a percentage of the injected dose, was 27%, with a range from 16% to 45% (calculated from columns 2 and 3 in table 1). Figure 3 shows the similarity in the percentage distribution between the major plasma lipoproteins of labeled cholesteryl ester derived from the injected d < 1.019 lipoproteins and from chylomicrons. Apparently, the cholesteryl esters in both injected lipoprotein fractions undergo exchange with the other lipoproteins to a similar extent. 1213 'Animals 1,2,4, and 7 were injected with lipoprotein preparations from the same two donor animals. Animals 3, 4, and 6 were injected with preparations from two other donor animals. tRadioactivity in the tissue was corrected for radioactivity in contaminating plasma, intima media: 0.3 /il/g and liver 62 /xl/g. This correction reduced radioactivity in intima media by 5%-10% and liver by 30%-50% (see ref. 8 ). Table 1 shows data for the labeled cholesteryl ester as a percentage of the injected chylomicron and d < 1.019 doses in plasma, intima media, and liver. The tissue radioactivities were corrected for radioactivity in contaminating plasma. This correction was based on the radioactivity per ml of terminal plasma and on the volume of plasma left in the tissue. The amount of plasma left in each tissue had been previously measured in five animals, which were fed the same diet as the animals in this experiment and were killed and perfused in an identical manner 5 minutes after an intravenous injection of plasma d > 1.21 protein fraction labeled in vivo with 3 H-leucine. 8 The largest tissue uptake values for labeled chylomicron esterified cholesterol were for the liver, in which between 0.06% and 0.16% of the injected chylomicron cholesteryl ester was present per gram of tissue between 1 and 4 hours after injection. The tissue uptakes for intima media were about one-tenth of this amount.
Labeled Cholesteryl Ester In Tissue
Direct Uptake of Chylomicron Cholesteryl Ester
In figure 4 , the uptake of 14 C-cholesteryl ester from chylomicrons by aorta is shown diagrammatically. Chylomicrons may be adsorbed on the arterial surface and converted to remnants by locally present lipoprotein lipase. The internalization of the remnant cholesteryl ester by endothelial, smooth muscle cells, or by macrophages would represent the direct uptake route. The transfer of 14 C-cholesteryl ester to other plasma lipoproteins by exchange 1213 or by a metabolic transformation of chylomicrons to the lipoproteins in higher density classes, 14 results in the incorporation of 14 C-cholesteryl ester label in these fractions. Subsequent deposition of this 14 C-cholesteryl ester would represent the indirect pathway. It is assumed that the metabolic fate of the 14 C-cholesteryl ester diverted to the indirect pathway mimics the fate of 3 H-cholesteryl ester which was originally injected intravenously as plasma d < 1.019 cholesteryl ester. The simultaneous injection of the two labeled cholesteryl ester preparations makes it possible to distinguish between the direct and indirect uptake pathways.
The assumption that the cholesteryl ester of chylomicron remnants equilibrates rapidly with the VLDL and other cholesteryl esters in plasma or is metabolized like the cholesteryl esters in other lipoprotein complexes is borne out in part by the data in figure 3 , which show that the transfer of 14 C-and ^-cholesteryl ester to the higher density lipoprotein fraction proceeds in parallel during the experimental period. Therefore, the total amount of 14 C-cholesteryl ester (from chylomicrons) reaching a tissue t(°E) equals the amount of labeled cholesteryl ester transferred directly from labeled chylomicrons to tissue (°C), which probably takes place during the first 20-30 minutes after the intravenous dose, plus an amount reaching the tissue by means of the other plasma lipoproteins (i.e., indirect uptake). The latter quantity equals the amount of tissue 3 H-cholesteryl ester, derived from injected d < 1.019 plasma lipoproteins, times the ratio of plasma concentrations of 14 C-to 3 Hesterified cholesterol averaged over the experimental period, i.e., P(°E)/P(*E). This is summarized as: in which the plasma and tissue radioactivity terms are expressed as fractions of their respective injected doses, °D and *D. Table 2 (column A) lists, for aortic intima media and liver, the percentage of the injected labeled chylomicron cholesteryl ester which reached the tissue by the direct and by the indirect pathways.
The indirect uptake of cholesteryl ester label by aorta is considerably greater than the direct uptake. This is a consequence of the disappearance of injected chylomicrons in 20 to 30 minutes and a considerable transfer of labeled cholesteryl ester to other plasma lipoproteins, which then, in turn, contribute their cholesteryl ester to the artery. If one assumes that the removal rate of injected chylomicrons resembles that of native chylomicrons, one can calculate the nmoles of chylomicron cholesteryl ester transferred to the aorta by the direct pathway (column B, table 2) in a rabbit fed 500 mg (1.3 mmol) of cholesterol per day. In such an animal, approximately 300 mg (0.78 mmol) of diet-derived cholesteryl ester enters the plasma each day. If chylomicron cholesteryl ester uptake by the aorta is proportional to plasma chylomicron cholesteryl ester concentrations, then multiplication of the figures in column A of table 2 by 0.78 gives the nmoles of chylomicron cholesteryl ester expected to enter the aorta daily by the direct pathway. The range of values from -11.0 to 8.8 nmol/g tissue/day shows that, on the average, the direct transfer of dietary cholesterol to the arterial wall by deposition of chylomicrons does not differ significantly from zero. The small negative values for Column A: Direct uptake of chylomicron cholesteryl ester calculated from Equation 2. Indirect uptake is the difference between the % dose/g in table 1 (shown as "Total") and direct uptake.
Column B: A x 0.78 (A rabbit fed 500 mg cholesterol/ day contributed about 300 mg, or 0.78 mmol of dietary esterified cholesterol/day to plasma). the lower end of the range reflect measurement errors.
If a rabbit liver weighs 100 g, the highest observed value for direct uptake of chylomicron cholesteryl ester (817 nmol/g/day) would represent a chylomicron cholesteryl ester uptake of 81.7 /nmol/day. This, compared to a chylomicron cholesteryl ester influx into plasma of 780 /^mol, represents only about 10% of the daily chylomicron cholesteryl ester turnover.
Discussion
Chylomicron cholesteryl ester could, in principle, contribute to arterial cholesteryl ester by a direct deposition pathway, or indirectly by degradation to circulating remnants and subsequent deposition of these secondary particles or parts thereof. 1 In this study we introduced into the plasma of hypercholesterolemic rabbits two types of cholesteryl ester-labeled particles: 1) lymph chylomicrons, and 2) plasma very low density lipoproteins (VLDL). We assumed that the indirect pathway by which chylomicron cholesteryl ester is transferred to a tissue is similar to that taken by plasma VLDL cholesteryl ester, and that the total transfer of labeled chylomicron cholesteryl ester to the tissue must be decreased by the indirect transfer to obtain the rate at which chylomicron cholesteryl ester is contributed to the aorta by a direct interaction of the chylomicron with the arterial wall.
It is likely that the direct uptake of chylomicron cholesteryl ester occurs within minutes after the chylomicron is introduced into the bloodstream, because the half-life of lymph chylomicron triglyceride in plasma of hypercholesterolemic rabbits is less than 10 minutes. 6 Yet there is reason to believe that a high proportion of the chylomicrons associated with arterial tissue early after intravenous injection might represent chylomicrons during their transition to chylomicron remnants while in contact with endothelial cells. We would expect that most of these remnants would be released back into the bloodstream and that their cholesteryl ester content would not contribute to arterial lesions. To avoid measuring the chylomicron cholesteryl ester residing temporarily at the arterial surface, we terminated the experiments between 1 and 5 hours after the injection of the chylomicron dose. Because of these longer influx periods, we have to take into account the uptake of labeled cholesteryl ester by the indirect pathway.
To gain a perspective on the contribution of chylomicrons to the atherogenic process, we should compare the arterial influx of chylomicron cholesteryl ester to the arterial cholesteryl ester uptake from the other plasma lipoprotein fractions. We previously showed that the arterial influx of VLDL esterified cholesterol in the hypercholesterolemic rabbit was about one-third that of low density lipoprotein (LDL) when the plasma concentrations of these fractions were the same. 25 This relation, combined with the 3 Hcholesteryl ester specific activities in the plasma d < 1.019 and d > 1.019 and the level of 3 H-cholesteryl ester in the aortic tissue of the present study, makes it possible to calculate the sum of arterial uptake of cholesteryl ester from the d < 1.019 and d > 1.019 lipoproteins. In these rabbits, the sum of the uptakes from both fractions was about 1200 nmol/g/day. That value is close to the arterial cholesteryl ester influx of about 1300 nmol/g/day reported in another study of hypercholesterolemic rabbits in which cholesteryl ester in plasma had a uniform specific activity. 8 Compared to this cholesteryl ester influx via plasma lipoproteins other than chylomicrons, the cholesteryl ester contributed by the direct transfer of chylomicron cholesteryl ester to the artery was less than 1%. Even if we ascribed all the 14 C-cholesteryl ester in the arterial wall to the direct uptake of chylomicrons instead of to the sum of the direct and indirect uptake pathways, this maximal value for direct uptake (6-66 nmol/g/day, table 2) would amount to less than 5% of the total plasma cholesteryl ester influx into intima-media.
In a previous study, 5 the influx of VLDL, LDL, and high density lipoprotein (HDL) cholesteryl ester into intima-media was found to be inversely related to their molecular diameter. The present finding, that chylomicrons contribute little or no cholesteryl ester to the artery by a direct transfer, is compatible with this inverse relationship. Our present findings appear to differ, however, from studies in which significant triglyceride uptake by the perfused rabbit aorta was demonstrated. 15 The inverse relationship between lipoprotein cholesterol influx and lipoprotein diameter appears to minimize the role of cell surface receptors in the aortic cholesterol influx process. It is possible, of course, that the presence of severe hypercholesterolemia may have suppressed cell surface receptor activity, which under milder conditions could have exerted a selective effect on lipoprotein uptake by the artery.
According to the average value, calculated from the data in column A of table 2, a 100 g liver would have removed approximately 6% of the labeled chylomicron cholesteryl ester dose from plasma by the direct removal pathway. This small uptake of chylomicron cholesteryl ester by the liver is in agreement with the relatively low uptake of chylomicrons by perfused rat livers. 16 * 18 In conclusion, the present study is compatible with the view that the transfer of cholesteryl ester from the plasma to the intima-media layer of the thoracic aorta in a cholesterol-absorbing rabbit includes only a negligible contribution directly from the chylomicrons, compared to the contribution from other plasma lipoproteins.
